SNCA

gene product
alpha-synuclein, NACP, PARK1, PARK4, PD1
Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Four alternatively spliced transcripts encoding two different isoforms have been identified for this gene. [provided by RefSeq, Mar 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
1157 antibodies from 35 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Novus Biologicals
41 antibodies
Enzo Life Sciences
8 antibodies
Abnova Corporation
36 antibodies
antibodies-online
478 antibodies
Biosensis Pty Ltd
3 antibodies
Cell Signaling Technology, Inc
8 antibodies
Proteintech Group
1 antibody
Thermo Fisher Scientific Pierce
18 antibodies
GeneTex
18 antibodies
Atlas Antibodies
1 antibody
R&D Systems
4 antibodies
Acris Antibodies GmbH
90 antibodies
Aviva Systems Biology
25 antibodies
Biorbyt
59 antibodies
Signalway Antibody LLC
8 antibodies
Abgent
7 antibodies
LifeSpan BioSciences, Inc.
117 antibodies
Sino Biological Inc.
2 antibodies
Rockland Immunochemicals, Inc.
1 antibody
Creative Biomart
85 antibodies